Antibody response to DNA vaccine against H5N1 avian influenza virus in broilers immunized according to three schedules.

Anna Stachyra; Anna Góra-Sochacka; Włodzimierz Zagórski-Ostoja; Ewelina Król; Agnieszka Sirko

doi:10.18388/abp.2014_1881

Antibody response to DNA vaccine against H5N1 avian influenza virus in broilers immunized according to three schedules.

Anna Stachyra Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.;
Anna Góra-Sochacka Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.;
Włodzimierz Zagórski-Ostoja Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.;
Ewelina Król Department of Recombinant Vaccines, Intercollegiate Faculty of Biotechnology, University of Gdansk and Medical University of Gdansk, Gdańsk, Poland.;
Agnieszka Sirko Institute of Biochemistry and Biophysics, Polish Academy of Sciences, Warsaw, Poland.;

DOI: https://doi.org/10.18388/abp.2014_1881

Abstract

Broiler type chickens were immunized intramuscularly with a DNA vaccine encoding hemagglutinin (HA) from H5N1 avian influenza virus. The chickens were divided into four groups: control group which was not immunized, a group which obtained only one dose, and two groups which were immunized twice, one group with a boost two weeks after the priming and the other four weeks. Blood samples were collected at several time points and the dynamics of the humoral response to the vaccine was studied. High level of anti-HA antibodies was detected only in the last two groups, that is in chickens immunized according to the prime-boost strategy, regardless of the schedule. An additional interesting observation of this study was detection of the cross-reactivity of an anti-H5 HA positive serum with H5N2 and H1N1 viruses, suggesting that the DNA vaccine tested can induce antibodies of a broad specificity.

Published

2014-09-01

Issue

Vol. 61 No. 3 (2014): Influenza virus

Section

Articles

Acta Biochimica Polonica is an OpenAccess quarterly and publishes four issues a year. All contents are distributed under the Creative Commons Attribution-ShareAlike 4.0 International (CC BY 4.0) license. Everybody may use the content following terms: Attribution — You must give appropriate credit, provide a link to the license, and indicate if changes were made. You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.